Editas Medicine, Inc. short interest in 2020
In 2020, Editas Medicine, Inc.'s disclosed short interest ran from 17.65% of shares outstanding on 15 Jan 2020 to 15.87% on 31 Dec 2020, a change of -1.78 percentage points. The year's high was 18.15% on 15 Oct 2020 and its low 14.15% on 31 Mar 2020, averaging 16.10% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.15 days on 30 Oct 2020. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 17.65% (15 Jan 2020)
- End of year
- 15.87% (31 Dec 2020)
- Change
- -1.78 pp
- High
- 18.15% (15 Oct 2020)
- Low
- 14.15% (31 Mar 2020)
- Average
- 16.10%
- Highest days to cover
- 17.15 (30 Oct 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 17.65% | 14.54 | |
| 31 Jan 2020 | 17.43% | 15.41 | |
| 14 Feb 2020 | 15.77% | 12.28 | |
| 28 Feb 2020 | 14.91% | 8.13 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 15.52% | 7.73 | |
| 31 Mar 2020 | 14.15% | 6.39 | |
| 15 Apr 2020 | 14.89% | 11.26 | |
| 30 Apr 2020 | 14.75% | 13.55 | |
| 15 May 2020 | 15.00% | 9.27 | results (8-K), 10-Q filed |
| 29 May 2020 | 15.11% | 9.50 | |
| 15 Jun 2020 | 16.52% | 13.02 | |
| 30 Jun 2020 | 17.09% | 4.93 | |
| 15 Jul 2020 | 16.13% | 9.25 | |
| 31 Jul 2020 | 14.19% | 13.46 | |
| 14 Aug 2020 | 14.82% | 8.01 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 14.72% | 16.92 | |
| 15 Sep 2020 | 15.64% | 11.69 | |
| 30 Sep 2020 | 16.82% | 13.09 | |
| 15 Oct 2020 | 18.15% | 11.90 | |
| 30 Oct 2020 | 18.12% | 17.15 | |
| 13 Nov 2020 | 18.05% | 12.15 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 17.74% | 16.59 | |
| 15 Dec 2020 | 17.47% | 3.09 | |
| 31 Dec 2020 | 15.87% | 2.95 |
See also: Editas Medicine, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.